Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Health Discovery Corporation (HDVY)

HDVY RSS Feed
Add HDVY Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 9/23/2014 5:37:17 PM - Followers: 93 - Board type: Free - Posts Today: 0

 

 HDVY information: (check the stickies for the latest information)

HDVY 12/10/10 Share structure: 

O/S  247,350,747
A/S 300,000,000

Health Discovery Corporation
2 East Bryan Street, Suite 601
Savannah, Georgia 31401

Phone: 912.443.1987
912.443.1988
Fax: 912.443.1989

investor@healthdiscoverycorp.com

 

Updates:


2/11/2011 Form 10-Q/A      http://yahoo.brand.edgar-online.com/DisplayFiling.aspx?dcn=0001188112-11-000245

1/05/2011  Form 8-K

12/30/2010  Form 8-K 

12/10/10 Securities Registration Statement (S-1) 

11/15/2010: Latest 10-Q released

11/2/2010: Health Discovery Corp. awarded a $244,479.25 Qualifying Therapeutic Discovery Project (QTDP) Grant

To view all SEC filings please visit   http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001141788&owner=include 

To view the Shareholder Letter from Dr. Barnhill, dated 8/26/2010:  http://www.healthdiscoverycorp.com/pr.php#

5/16/10: Health Discovery Corporation Receives Prestigious MICO Award from MDB Capital Group LLC (click on the link above and see the item dated Feb. 26, 2010)

1/28/2010: HIGHEST VOLUME IN HISTORY. OVER 10 MILLION SHARES

10/20/2009: New 5 year high

 A link to all PR's is found on the company website some are linked below!!

http://healthdiscoverycorp.com/pr.php#

 

Tom Gallagher added to the team Ex Goldman VP seems to have a credential or two!!!

http://healthdiscoverycorp.com/pr/nov30_09.html 11/30/2009

47Patents held by HDVY!! 47 and 34 more pending!!!!

http://www.healthdiscoverycorp.com/intellectual.html 06/21/2010

Global PR firm hired to represent HDVY only the best!!!

http://healthdiscoverycorp.com/pr/oct09_09.html  10/9/2009

 

 What does it mean when the Ex FDA Commissioner is signed for a 4 month contract and your about launch a Prostate test with Quest and Abbott? $$$$

http://healthdiscoverycorp.com/pr/sep18_09.html 09/18/2009

Peer review published in UroToday Journal of Medicine highlighting HDVY's Prostate test 7/14/2009

http://healthdiscoverycorp.com/pr/july14_09.html

 

Deal with Quest :  http://www.healthdiscoverycorp.com/pr/feb5b_09.html  2/5/2009
Deal with Abbott : http://www.healthdiscoverycorp.com/pr/feb5a_09.html 2/5/2009

Prostate tissue test launch HDC to recieve 30% of all proceeds. Hints at more tests soon and hires firm to monetize IP portfolio. 8/7/2008

 From the CEO of IPotential a leading IP Patent law firm. Google IPotential and see the huge list of household name clients they have represented. Now see what the CEO says about HDVY!!"We are pleased to initiate our relationship with such a unique innovator like Health Discovery Corporation," said Ron Epstein, CEO of IPotential. "HDC's seminal SVM patents have broad applicability wherever large amounts of complex data must be manipulated mathematically. SVM technology will play a critical role in the development of the next generation of Internet search and anti-spam as well as a broad array of artificial intelligence products. We know that SVMs using HDC's patented technologies are broadly deployed across many markets and we look forward to working with the company in both publicizing and protecting its valuable IP."


_________________________________________________________________


ALL PRESS RELEASES ARE ON THE HDC WEBSITE
Tons of info and software examples on the HDC website.
http://www.healthdiscoverycorp.com/#



_________________________________________________________________




HDVY's website with PR's, Bios, Updates, read up and do your own DD, but the people involved are top notch. There is no toxic dilution, the CEO took  a pay cut to stave off dilution at one point in time, these are very wealthy people involved here with real reputations to protect. They have already made their money they are not here to line their pockets, but to build a legacy and  R&D  with partner with other Pharms/Biotechs for better solutions save lives.  

 http://www.healthdiscoverycorp.com/

 

"Major Partnerships w/ Pfizer (NYSE), Abbott (NYSE), Quest Diagnostics (NYSE), CLRT (NASD), IART (NASD), BRKR (NASD) . These FORTUNE 500 companies have to pay royalty fees forever to these HDVY since HDVY licenses their SVM-RFE Technology to them and this company is not even $1.00. VRLMQ went from .06 to almost $20/share on the approval of the OVA (Ovarian Test) using the technology licensed to them by HDVY. Demonstrates how undervalued HDVY is at .38.

HDC’s License Partners (From 10/19/09 PR)

HDC’s key license partners to date include Abbott Laboratories (NYSE: ABT - News), Quest Diagnostics (NYSE: DGX - News), Clarient Inc. (Nasdaq: CLRT - News) and Pfizer Inc. (NYSE: PFE - News).
HDC recently entered into royalty-bearing licenses for its new urine-based prostate cancer test with Quest Diagnostics Incorporated and Abbott Laboratories for development and commercialization. These licenses are solely for the use of HDC’s prostate cancer biomarkers in urine.
HDC also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories and Clarient Inc. for development and commercialization. This license is solely for the use of HDC’s prostate cancer biomarkers in tissue biopsy specimens.
HDC has also partnered with Pfizer Inc. for use of HDC’s SVM and SVM-RFE pattern recognition technology in Pfizer’s global research and development.
HDC has also entered into a license with Smart Personalized Medicine, LLC (“SPM”), a privately-held company, founded by Dr. Richard Caruso, Chairman and founder of Integra Life Sciences (NasdaqGS: IART - News) to develop a superior breast cancer prognostic test using HDC’s SVM technology in cooperation with MD Anderson Cancer Center. HDC has a fifteen percent equity position in SPM and HDC will receive royalties from this new breast cancer prognostic test.
HDC has entered into a development and license agreement with DCL Medical Laboratories, LLC, for the collaborative development and commercialization of SVM-based computer assisted diagnostic tests for the independent detection of ovarian, cervical and endometrial cancers.
HDC’s Patents Cover Non-Medical Applications
There are a large number of non-medical applications protected by HDC’s patents, including but not limited to, fraud detection, investment and commodities price predictions, bankruptcy prediction, image and object analysis, face recognition, text and document classification, speech recognition, personalized consumer purchasing patterns, decryption, vehicle control and monitoring, weather forecasting and database marketing.
Total Number of Patents Pending and Issued
With the issuance of the new patents described above, HDC now holds exclusive rights to a total of 37 issued U.S. and foreign patents. There will be 41 when the 4 new ones (subjects of the Notices of Allowance) issue in the next few months. HDC has a total of 71 patents pending and issued. Importantly, the first expiration of any of the HDC patents is May 2019 and new patents are currently being filed which when granted will have an additional 20 years of protection for the Company.
HDC’s Successful Prosecution of Patent Infringement Cases
In addition to the Vermillion patent infringement case described above, HDC successfully prosecuted a patent infringement lawsuit against Equbits LLC, which resulted in a permanent injunction against Equbits, LLC.
“HDC is determined to continue to grow and protect its valuable intellectual property portfolio. The Equbits judgment and Vermillion settlement and limited license strengthens our licensing posture in the marketplace and sets the appropriate tone for our future enforcement efforts,” stated Stephen D. Barnhill, M.D., HDC’s Chairman and CEO.
“HDC remains firmly committed to successfully monetizing our valuable intellectual property through additional licensing, close collaboration, development and commercialization with our business partners and we will also continue to protect our patent portfolio through robust enforcement action when strategically appropriate," said Dr. Barnhill.
HDC’s patent strategy includes a significant after-claiming component with multiple CIP’s and Continuations already in place. 




HDC has the only issued patents in the world for the SVM-RFE technology, which was discovered by members of the HDC science team. The SVM-RFE technology was the method used to discover the Company’s new tissue and urine based prostate cancer tests recently licensed to Quest Diagnostics (NYSE: DGX - News), Abbott Laboratories (NYSE: ABT - News) and Clarient Inc. (Nasdaq: CLRT - News).


Kary B. Mullis won the Nobel Prize in Chemistry in 1993
Kary Mullis Ph.D. is a Biochemist who got the 1993 Nobel prize for his invention of the Polymerase Chain Reaction, a technique used in AIDS tests
http://www.virusmyth.com/aids/index/kmullis.htm


Former Deputy FDA Commissioner John Norris Appointed Chief OperatingOfficer at Health Discovery Corporation.
http://www.allbusiness.com/medicine-health/diagnostics-screening-testing/13114880-1.html
Health Discovery Corporation (OTCBB:HDVY), a personalized medicinecompany specializing in molecular diagnostics including gene-based testing, as well as computer assisted diagnostics in digital pathologyand radiology, announced that former Deputy FDA Commissioner John A.Norris has been appointed as Chief Operating Officer (COO) of the Company. He will be responsible for business development, primarily creating new strategic partnerships, licenses and contracts to complement the Company's existing agreements with Quest Diagnostics, Abbott Molecular, Pfizer, Bruker and Clarient (see also Health Discovery Corporation ).
"We are extremely fortunate to have attracted someone of John Norris' caliber," said Stephen D. Barnhill, M.D., chairman and CEO of Health Discovery Corporation (HDC). "We expect that his extensive experience and vast relationships in the healthcare space will make a very meaningful contribution to our growth trajectory. John is a visionaryleader who understands how the groundbreaking analytics that we havedeveloped and patented could change the face of diagnostic testing for personalized medicine. His extensive knowledge of the business of healthcare around the world will help us accelerate the commercialization of HDC's new gene-based urine test for prostate cancer."
According to Mr. Norris, "Dr. Barnhill has assembled a world-classteam of researchers, investigators and advisors who have pioneered abold new approach to diagnostics that will vastly improve the speed and accuracy of testing in the realm of gene-based testing, as well as in digital pathology and digital radiology." HDC holds 72 critical patents that are central to the digital convergence of diagnostics, pathology and radiology. "I am very pleased to be part of this outstanding team," Mr. Norris added.
"Our patented Support Vector Machine and Recursive Feature Elimination pattern recognition technologies have been independently validated by top researchers, academics and business professionals around the world and published in dozens of peer-reviewed medical and scientific journals and have broad applicability wherever highly accurate conclusions must be drawn from vast amounts of complex data," Dr. Barnhill said.
Dr. Barnhill continued, "In addition, we expect that John will be a huge asset in promoting our gene-based test for clinically significant prostate cancer recently licensed for commercialization to Abbott, Quest Diagnostics, and Clarient. Right now, half a million men a year in the United States alone have painful, expensive but unnecessarybiopsies for prostate cancer based solely on PSA findings, the current world standard for prostate cancer screening. The previously-announced results of our forthcoming urine-based test for prostate cancer could eliminate many of these unnecessary biopsies and unnecessary treatments such as radical prostate surgery stemming from false positive readings on the PSA test."


PATENTS
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6,944,602.PN.&OS=PN/6,944,602&RS=PN/6,944,602

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=health+discovery&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT


Prostate Cancer Quotes




Insight DX Test



http://www.urotoday.com/index.php?option=com_uij&view=single&issnum=8&volnum=2§ionid=27&Itemid=3369


Urology 1




Leukemia Test


BPH Test


CRC Test


AIDS Test

VIDEOS

 

This is by "Isabella Guyon" who is one of the primary inventors of many asspects that Dr. Barnhill is and has worked with, enjoy and try to listen to this self run teaching for say 15-20 minutes.

http://videolectures.net/bootcamp07_guyon_itml/

Here is our gifted "Bernhard Scholkopf" giving his lecture about machine learning, learning with kernels, mind you this is probably the 10th year of summer school lecture and it isn't summer school for dummies basically for PDd's etc
http://videolectures.net/mlss07_scholkopf_intkmet/

 

Health Discovery Corporation Intellectual Property

Patent Office & Number

Description

U.S. Patent No. 6,128,608

Enhancing Knowledge Discovery Using Multiple Support Vector Machines

U.S. Patent No. 6,157,921

Enhancing Knowledge Discovery Using Support Vector Machines in a Distributed Network Environment

U.S. Patent No. 6,427,141

Enhancing Knowledge Discovery Using Multiple Support Vector Machines.

U.S. Patent No. 6,658,395

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

U.S. Patent No. 6,714,925

System for Identifying Patterns in Biological Data Using a Distributed Network.

U.S. Patent No. 6,760,715

Enhancing Biological Knowledge Discovery Using Multiple Support Vector Machines.

U.S. Patent No. 6,789,069

Method of Identifying Patterns in Biological Systems and Method of Uses.

U.S. Patent No. 6,882,990

Method of Identifying Biological Patterns Using Multiple Data Sets.

U.S. Patent No. 6,944,602

Spectral Kernels for Learning Machines

U.S. Patent No. 6,996,542

Computer-Aided Image Analysis

U.S. Patent No. 7,117,188

Methods of Identifying Patterns in Biological Systems and Uses Thereof

U.S. Patent No. 7,299,213

Method of Using Kernel Alignment to Extract Significant Features from a Large Dataset

U.S. Patent No. 7,318,051

Methods for Feature Selection in a Learning Machine

U.S. Patent No. 7,353,215

Kernels and Methods for Selecting Kernels for Use in a Learning Machine

U.S. Patent No. 7,383,237

Computer-Aided Image Analysis

U.S. Patent No. 7,444,308

Data Mining Platform for Bioinformatics and Other Knowledge Discovery

U.S. Patent No. 7,475,048

Pre-Processed Feature Ranking for a Support Vector Machine

U.S. Patent No. 7,542,947

Data Mining Platform for Bioinformatics and Other Knowledge Discovery

U.S. Patent No. 7,542,959

Feature Selection Using Support Vector Machine Classifier

U.S. Patent No.  7,617,163

Kernels and Kernel Methods for Spectral Data

U.S. Patent No. 7,624,074

Methods for Feature Selection in a Learning Machine

Australian Patent No. 764897

Pre-processing and Post-processing for Enhancing Knowledge Discovery Using Support Vector Machines.

Indian Patent No. 212978

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

South African Patent No. 00/7122

Pre-processing and Post-processing for Enhancing Knowledge Discovery Using Support Vector Machines.

Australian Patent No. 780050

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Chinese Patent No. ZL00808062.3

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

European Patent No. 1192595

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

German Patent No. DE60024452.0-08

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

Indian Patent No. 223409

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Israeli Patent No. 146705

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Norwegian Patent No. 319,838

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines.

South Korean Patent No. 724104

Enhancing Knowledge Discovery from Data Sets Using Multiple Support Vector Machines

Australian Patent No. 779635

Method of Identifying Patterns in Biological Systems and Method of Uses.

Australian Patent No. 2002243783

Computer Aided Image Analysis

European Patent No. 1356421

Computer Aided Image Analysis

Japanese Patent No. 3947109

Computer Aided Image Analysis

Australian Patent No. 2002253879

Methods of Identifying Patterns in Biological Systems and Uses Thereof

Japanese Patent No. 4138486

Methods of Identifying Patterns in Biological Systems and Uses Thereof

Canadian Application No. 2,330,878

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

European Publication No. 1082646

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

Hong Kong Application No. 011065063

Pre-Processing and Post-Processing for Enhancing Knowledge Discovery Using Support Vector Machines

Canadian Application No. 2,371,240

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Japanese Application No. 2000-620577

Enhancing Knowledge Discovery from Multiple Data Sets Using Multiple Support Vector Machines

Canadian Application No. 2,388,595

Method of Identifying Patterns in Biological Systems and Method of Uses

European Publication No. 1236173

Method of Identifying Patterns in Biological Systems and Method of Uses

Japanese Application No. 2001-534088

Method of Identifying Patterns in Biological Systems and Methods of Uses

U.S. Patent Publication No. 2005/0165556

Colon Cancer-Specific Markers

U.S. Patent Publication No. 2008/0059392

System for Providing Data Analysis Services Using a Support Vector Machine for Processing Data Received from a Remote Source

European Publication No. 1828917

Biomarkers for Screening, Predicting, and Monitoring Prostate Disease

Canadian Application No. 2,435,254

Methods of Identifying Patterns in Biological Systems and Uses Thereof

European Publication No. 1459235

Methods of Identifying Patterns in Biological Systems and Uses Thereof

U.S. Patent Publication No. 2008/0301070

Kernels and Methods for Selecting Kernels for Use in a Learning Machine

Canadian Application No. 2,435,290

Computer Aided Image Analysis

U.S. Patent Publication No. 2008/0140592

Model Selection for Cluster Data Analysis

U.S. Patent Publication No. 2008/0097938

Data Mining Platform for Knowledge Discovery from Heterogeneous Data Types and/or Heterogeneous Data Sources

U.S. Patent Publication No. 2008/0097940

Kernels and Kernel Methods for Spectral Data

U.S. Application No. 12/700,575

Support Vector Machine-Based Method for Analysis of Spectral Data

U.S. Patent Publication No. 2008/0233576

Pre-Processed Feature Ranking for a Support Vector Machine

European Publication No. 1449108

Pre-Processed Feature Ranking for a Support Vector Machine

U.S. Patent Publication No. 2008/0050836

Biomarkers for Screening, Predicting, and Monitoring Benign Prostate Hyperplasia

European Publication No. 1828917

Biomarkers for Screening, Predicting, and Monitoring Prostate Disease

U.S. Patent Publication No. 2009/0215024

Biomarkers Upregulated in Prostate Cancer

U.S. Patent Publication No. 2009/0286240

Biomarkers Overexpressed in Prostate Cancer

U.S. Patent Publication No. 2009/0215058

Methods for Screening, Predicting and Monitoring Prostate Cancer

U.S. Patent Publication No. 2009/0226915

Methods for Screening, Predicting and Monitoring Prostate Cancer

PCT Application No. US2009/66873

Methods for Screening, Predicting and Monitoring Prostate Cancer

U.S. Patent Publication No. 2009/0305257

Biomarkers Downregulated in Prostate Cancer

U.S. Patent Publication No. 2009/0204557

Method and System for Analysis of Flow Cytometry Data Using Support Vector Machines

PCT Publication No.

WO 2009/100410

Method and System for Analysis of Flow Cytometry Data Using Support Vector Machines

U.S. Provisional Application No. 61/289,372

Remote Melanoma Diagnosis Using a Smart Phone

U.S. Provisional Application No. 61/293,987

System and Method for Remote Melanoma Screening Using a Smart Phone

U.S. Provisional Application No. 61/304,796

System and Method for Remote Melanoma Screening

FGM Patents and Applications:

U.S. Patent No. 6,920,451

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets.

U.S. Patent No. 7,366,719

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets

European Patent No.: 1252588

Method for the Manipulation, Storage, Modeling, Visualization and Quantification of Datasets.

 



Health Discovery Corporation
2 East Bryan Street, Suite 601
Savannah, Georgia 31401

Phone: 912.443.1987
912.443.1988
Fax: 912.443.1989
Thomas L. Gallagher: President, Chief Operating Officer and General Counsel

investor@healthdiscoverycorp.com

 


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
HDVY
Current Price
Volume:
Bid Ask Day's Range
Wiki
HDVY News: Quarterly Report (10-q) 08/14/2014 03:20:48 PM
HDVY News: Quarterly Report (10-q) 05/15/2014 02:09:11 PM
PostSubject
#10966   So we are still alive or breathing with LocWolf 09/23/14 05:37:16 PM
#10965   What's the timeline on patent expiration? dayneyus 09/22/14 01:27:06 PM
#10964   If they launch after the patents expire, maybe king oil 09/21/14 06:39:02 PM
#10963   It looks like NEO Will Wait Till 1Qtr dayneyus 09/21/14 05:02:29 PM
#10962   Interesting volume and SVM capital may be the spongiformbobsqpants 09/15/14 01:41:10 AM
#10961   True, you did, and several people got excessively king oil 08/19/14 01:33:29 PM
#10960   "If Neo test isn't launched, it's lights out sunspotter 08/15/14 04:41:12 AM
#10959   It's a slow painful death. The Neo king oil 08/14/14 06:58:19 PM
#10958   Sub-penny, baby! Man...what a POS. imperativity 08/14/14 03:29:16 PM
#10957   It recovered most of the lost ground, so king oil 07/29/14 05:09:17 PM
#10956   Didn't have it on my radar today dayneyus 07/29/14 04:55:07 PM
#10955   Down 61% this morning, any idea what's up? king oil 07/29/14 09:51:33 AM
#10954   how's that transition to a commercially viable company going? king oil 07/22/14 12:13:02 PM
#10953   This looks more like a long painful death king oil 06/17/14 04:53:26 PM
#10952   Hi 'Boxsterfan' Just reacting to the volume, that dayneyus 06/01/14 10:17:57 PM
#10951   I think the "buyers" are just you pumping Boxsterfan 05/30/14 11:44:42 PM
#10950   After this weekend NEO could start the roll dayneyus 05/30/14 10:25:43 AM
#10949   We can hope. Price should have responded better though. king oil 05/29/14 10:37:36 PM
#10948   Volume Spike today could be leak on Neo's dayneyus 05/29/14 05:16:46 PM
#10947   Volume Spike today! dayneyus 05/29/14 05:15:21 PM
#10946   LocWolf The wait may be over! dayneyus 05/29/14 05:14:31 PM
#10945   From NEO prospectus just released. dayneyus 05/09/14 03:00:36 PM
#10944   The fact remains we are waiting as usual, LocWolf 05/04/14 11:28:42 PM
#10941   Hey HDVY'ers dayneyus 04/24/14 10:40:24 PM
#10940   Terry, hope all is well...just a note to LocWolf 04/10/14 11:02:47 AM
#10939   WELL! It seems that the 10-K filings for LocWolf 04/10/14 11:01:42 AM
#10938   A blast from the past. Sometimes I'm just sunspotter 01/13/14 10:36:24 AM
#10937   Terry: LocWolf 01/02/14 12:41:38 PM
#10936   What is really interesting look to the right LocWolf 12/16/13 01:10:39 PM
#10935   According to Barnhill's linkedin page HDC is profitable. Steady_T 12/14/13 01:29:19 PM
#10934   Karl, check this out.............. LocWolf 12/14/13 12:27:39 PM
#10933   Loc I rarely look at this board anymore. I Karlandang 12/05/13 02:51:40 PM
#10932   Karl, I believe with the alliance of Covance LocWolf 11/24/13 03:03:42 PM
#10931   Terry, no need to answer]eom LocWolf 10/29/13 12:20:35 PM
#10930   Hey there Terry LocWolf 10/29/13 12:13:43 PM
#10929   It would be nice if for once they king oil 10/27/13 11:31:24 AM
#10928   Looks like I misread the document. Thanks for Steady_T 10/27/13 02:46:46 AM
#10927   Exercise price is 0.036 king oil 10/26/13 10:57:00 PM
#10926   I'd be ecstatic if they get to exercise Steady_T 10/25/13 11:35:29 PM
#10925   Terry, check out HDCY give away shares.... LocWolf 10/25/13 04:57:38 PM
#10924   I meant, complete closure of the company, as LocWolf 10/18/13 01:01:30 PM
#10923   Terry, most can see that a couple of LocWolf 10/18/13 12:55:39 PM
#10922   You have to wonder if HDVY has ever king oil 10/18/13 12:15:00 PM
#10921   The gang that couldn't shoot straight provide more sunspotter 10/17/13 06:31:25 PM
#10920   Hang in here my friend, I have been LocWolf 09/14/13 02:08:01 PM
#10919   If you haven’t sold all HDC shares yet LocWolf 09/11/13 03:29:39 PM
#10918   King Oil, with respect there is far more LocWolf 08/20/13 12:11:55 AM
#10917   I have explained prior and will again what LocWolf 08/20/13 12:08:33 AM
#10916   B shares become common? king oil 08/15/13 11:38:13 AM
#10915   I would like many here to revaluate my LocWolf 08/14/13 08:34:55 PM
PostSubject